This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

$4.49 Million Jury Verdict Against Anthem Blue Cross For Excluding Dr. Jeffrey Nordella From Its Preferred Provider Network

LOS ANGELES, April 9, 2013 /PRNewswire/ --A Los Angeles jury awarded damages to Dr. Jeffrey Nordella, a primary care doctor for 22 years, after finding that Anthem Blue Cross violated his right to Fair Procedure when he applied to join the Anthem Blue Cross Provider Network.  Dr. Nordella claimed that Anthem Blue Cross excluded him from its Provider Network because he is an advocate for his patients.

Dr. Nordella is the medical director of Porter Ranch Quality Care in California, which serves patients in the San Fernando Valley. In March 2010, Anthem Blue Cross denied Dr. Nordella's application to join its Provider Network contending that it had "no need" for another General Practitioner in its Network.

Dr. Nordella, an ardent patient advocate, claimed during trial that Anthem Blue Cross, the largest for-profit health insurer in California, puts profits before patients by unlawfully excluding qualified doctors from its Provider Network.  Because of a shortage of primary care doctors, Nordella's attorney, Theresa Barta, told the jury that Blue Cross was not acting in the best interests of its members and exclusion of primary care doctors (such as Dr. Nordella) restricts access to healthcare.

The Los Angeles Superior Court jury awarded Dr. Nordella nearly $4.5 million in damages for lost salary and profits from his practice, but found him 15 percent responsible for his losses, resulting in a net award of $3.8 million.

The jury also found that Anthem Blue Cross acted with malice, oppression and fraud, setting the stage for a second phase of trial during which an award of punitive damages is possible.

"This verdict sends a message to doctors that they have a voice. They can stand up and fight back against insurers. This is a huge win, not only for my client, but for all physicians," said Theresa Barta.

Nordella is represented by Theresa J. Barta of the Law Offices of Theresa Barta in Newport Beach, California.  Anthem Blue Cross is represented by Ken Smersfelt and Junga Kim of Reed Smith LLP.

Phase II of the trial is set for Friday, April 12, 2013 at 10 a.m. in Los Angeles Superior Court, Stanley Mosk Courthouse, Department 71, Room 729, 111 North Hill Street, LA 90012.

Press Contact For Dr. Jeffrey Nordella, MD:Ann D'Amato, (310) 963-2981

SOURCE Jeffrey Nordella, MD

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,776.12 -200.19 -1.11%
S&P 500 2,067.89 -18.35 -0.88%
NASDAQ 4,900.8850 -46.5560 -0.94%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs